Correlation Between Mereo BioPharma and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Lyra Therapeutics, you can compare the effects of market volatilities on Mereo BioPharma and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Lyra Therapeutics.
Diversification Opportunities for Mereo BioPharma and Lyra Therapeutics
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mereo and Lyra is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Lyra Therapeutics
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Lyra Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Mereo BioPharma Group is 2.21 times less risky than Lyra Therapeutics. The stock trades about -0.22 of its potential returns per unit of risk. The Lyra Therapeutics is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 25.00 in Lyra Therapeutics on August 29, 2024 and sell it today you would lose (5.00) from holding Lyra Therapeutics or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Lyra Therapeutics
Performance |
| Timeline |
| Mereo BioPharma Group |
| Lyra Therapeutics |
Mereo BioPharma and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Lyra Therapeutics
The main advantage of trading using opposite Mereo BioPharma and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Mereo BioPharma vs. Bright Minds Biosciences | Mereo BioPharma vs. HP Inc | Mereo BioPharma vs. Intel | Mereo BioPharma vs. Chevron Corp |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |